Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Pepgen Corporation

Below is an extended Pepgen Corporation patents listing. Click here to return to the Pepgen Corporation main Biocorporate entry.

Pepgen Corporation Patents :

US Patent No.Title
7431920 Method of treating IL-10 deficiency
7232563 Hybrid interferon/interferon tau proteins, compositions and methods of use
7105154 Method of treatment using interferon-tau
7083782 Method of treatment using interferon-tau
6982081 Composition for treatment of and method of monitoring hepatitis C virus using interferon-TAU
6204022 Low-toxicity human interferon-alpha analogs

«Pepgen Corporation

This page contained an extended Pepgen Corporation patents listing. Click here to return to the Pepgen Corporation main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.